🇺🇸 FDA
Pipeline program

Placebo to AVTX-009, AVTX-009

AVTX-009-HS-201

Phase 2 small_molecule active

Quick answer

Placebo to AVTX-009, AVTX-009 for Hidradenitis suppurativa (HS) is a Phase 2 program (small_molecule) at Avalo Therapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
Avalo Therapeutics
Indication
Hidradenitis suppurativa (HS)
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials